NEW YORK (GenomeWeb News) – Bio-Reference Laboratories today reported that its first quarter revenues grew 12 percent, as the firm noted plans to expand its GeneDx business.

The Elmwood Park, NJ-based clinical lab firm reported revenues of $181.3 million for the three months ended January 31, up from $161.3 million for the first quarter of 2013. It beat the consensus Wall Street estimate of $171.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.